Literature DB >> 22180083

Progress in targeted delivery of siRNA to combat Coxsackievirus.

Anju Gautam1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22180083      PMCID： PMC4875187          DOI： 10.1007/s13238-011-1124-0

Source DB:  PubMed          Journal:  Protein Cell        ISSN： 1674-800X            Impact factor:   14.870


× No keyword cloud information.
  21 in total

Review 1.  siRNAs: applications in functional genomics and potential as therapeutics.

Authors:  Yair Dorsett; Thomas Tuschl
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

2.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

3.  Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.

Authors:  J M Bergelson; J A Cunningham; G Droguett; E A Kurt-Jones; A Krithivas; J S Hong; M S Horwitz; R L Crowell; R W Finberg
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

Review 4.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

6.  Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand.

Authors:  Ji Yuan; Paul K M Cheung; Huifang M Zhang; David Chau; Decheng Yang
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis.

Authors:  W M Klump; I Bergmann; B C Müller; D Ameis; R Kandolf
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

8.  In vitro mutational and inhibitory analysis of the cis-acting translational elements within the 5' untranslated region of coxsackievirus B3: potential targets for antiviral action of antisense oligomers.

Authors:  D Yang; J E Wilson; D R Anderson; L Bohunek; C Cordeiro; R Kandolf; B M McManus
Journal:  Virology       Date:  1997-02-03       Impact factor: 3.616

Review 9.  Viral infection and the pathogenesis of dilated cardiomyopathy.

Authors:  T A Martino; P Liu; M J Sole
Journal:  Circ Res       Date:  1994-02       Impact factor: 17.367

10.  Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs.

Authors:  Huifang M Zhang; Yue Su; Songchuan Guo; Ji Yuan; Travis Lim; Jing Liu; Peixuan Guo; Decheng Yang
Journal:  Antiviral Res       Date:  2009-07-16       Impact factor: 5.970
View more
  1 in total

1.  Crystal structure of enterovirus 71 RNA-dependent RNA polymerase complexed with its protein primer VPg: implication for a trans mechanism of VPg uridylylation.

Authors:  Cheng Chen; Yaxin Wang; Chao Shan; Yuna Sun; Peng Xu; Honggang Zhou; Cheng Yang; Pei-Yong Shi; Zihe Rao; Bo Zhang; Zhiyong Lou
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.